SC 13G/A |
Report
|
SC 13G/A |
Aug 2, 2024 |
|
SC 13G |
Report
|
SC 13G |
Feb 14, 2024 |
|
SC 13G/A |
Report
|
|
Feb 13, 2024 |
|
SC 13G/A |
Report
|
SC 13G/A |
Feb 13, 2024 |
|
SC 13G/A |
Report
|
SC 13G/A |
Feb 13, 2024 |
|
SC 13G/A |
Report
|
SC 13G/A |
Feb 9, 2024 |
|
SC 13G/A |
Report
|
SYROS PHARMACEUTICALS, INC. |
Feb 7, 2024 |
|
SC 13G |
Report
|
|
Jan 2, 2024 |
|
SC 13G/A |
Report
|
|
Feb 14, 2023 |
|
SC 13G/A |
Report
|
SC 13G/A |
Feb 14, 2023 |
|
SC 13G/A |
Report
|
SC 13G/A |
Feb 13, 2023 |
|
SC 13G/A |
Report
|
SC 13G/A |
Jan 30, 2023 |
|
SC 13G |
Report
|
SYROS PHARMACEUTICALS, INC. |
Jan 25, 2023 |
|
SC 13G/A |
Report
|
|
Nov 10, 2022 |
|
SC 13G |
Report
|
|
Sep 20, 2022 |
|
SC 13G |
Report
|
|
Sep 19, 2022 |
|
SC 13G |
Report
|
|
Jul 8, 2022 |
|
SC 13G/A |
Report
|
|
Apr 11, 2022 |
|
SC 13G/A |
Report
|
SC 13G/A |
Feb 14, 2022 |
|
SC 13G/A |
Report
|
SC13G/A |
Feb 14, 2022 |
|
SC 13G/A |
Report
|
SC 13G/A |
Feb 11, 2022 |
|
SC 13G |
Report
|
SC 13G |
Feb 11, 2022 |
|
SC 13G/A |
Report
|
|
Feb 9, 2022 |
|
SC 13G/A |
Report
|
AMENDMENT NO. 3 |
Feb 4, 2022 |
|
SC 13G/A |
Report
|
|
Feb 3, 2022 |
|
SC 13G/A |
Report
|
SC 13G/A |
Mar 10, 2021 |
|
SC 13G/A |
Report
|
SC 13G/A |
Feb 16, 2021 |
|
SC 13G/A |
Report
|
SCHEDULE 13G (AMENDMENT #1) |
Feb 16, 2021 |
|
SC 13G/A |
Report
|
SC 13G/A |
Feb 11, 2021 |
|
SC 13G/A |
Report
|
|
Feb 8, 2021 |
|
SC 13G/A |
Report
|
AMENDMENT NO. 2 |
Feb 5, 2021 |
|
SC 13G/A |
Report
|
ARCH VENTURE FUND VII, L.P. - SYROS PHARMACEUTICALS -- SCH 13G/A (#4E) |
Feb 2, 2021 |
|
SC 13G/A |
Report
|
|
Feb 1, 2021 |
|
SC 13G |
Report
|
SC 13G |
Dec 18, 2020 |
|
SC 13G |
Report
|
SC 13G |
Dec 14, 2020 |
|
SC 13G/A |
Report
|
SC 13G/A |
Oct 9, 2020 |
|
SC 13G |
Report
|
SCHEDULE 13G |
Apr 2, 2020 |
|
SC 13G/A |
Report
|
SC 13G/A |
Feb 14, 2020 |
|
SC 13G/A |
Report
|
ARCH VENTURE FUND VII, L.P. - SYROS PHARMACEUTICALS, INC. -- SCHEDULE 13G/A(#3) |
Feb 13, 2020 |
|
SC 13G/A |
Report
|
SC 13G/A |
Feb 12, 2020 |
|
SC 13G/A |
Report
|
FORM SC 13G/A |
Feb 12, 2020 |
|
SC 13G/A |
Report
|
|
Feb 7, 2020 |
|
SC 13G |
Report
|
|
Feb 7, 2020 |
|
SC 13G |
Report
|
|
Sep 9, 2019 |
|
SC 13G |
Report
|
SC 13G |
Sep 6, 2019 |
|
SC 13G/A |
Report
|
|
May 10, 2019 |
|
SC 13G |
Report
|
|
Apr 9, 2019 |
|
SC 13G/A |
Report
|
ARCH VENTURE FUND VII, L.P. - SYROS PHARMACEUTICALS, INC. -- SCHEDULE 13G/A(#2) |
Feb 14, 2019 |
|
SC 13G |
Report
|
SC 13G |
Feb 14, 2019 |
|
SC 13G/A |
Report
|
|
Feb 13, 2019 |
|
SC 13G |
Report
|
|
Feb 8, 2019 |
|
SC 13G/A |
Report
|
|
Feb 14, 2018 |
|
SC 13G/A |
Report
|
|
Feb 13, 2018 |
|
SC 13G/A |
Report
|
ARCH VII - SYROS PHARMACEUTICALS 13GA(#1) |
Feb 2, 2018 |
|
SC 13G/A |
Report
|
|
Feb 14, 2017 |
|
SC 13G/A |
Report
|
|
Feb 14, 2017 |
|
SC 13G/A |
Report
|
SYROS PHARMACEUTICALS, INC. -- SCHEDULE 13G/A (AMEND. #1) |
Feb 13, 2017 |
|
SC 13G |
Report
|
|
Jul 11, 2016 |
|
SC 13G |
Report
|
|
Jul 6, 2016 |
|